shortagewatch

Home / Zolmitriptan / Canada

CA ATC N02CC03 · updated 2 Nov 2026

Zolmitriptan shortage in Canada

Is there a Zolmitriptan shortage in Canada?

Yes. As of 2 Nov 2026, 13 Zolmitriptan products are reported short in Canada, the first since 14 Oct 2016. The company estimate for the return is 8 Sep 2028. Main reason: manufacturing problem.

Also short in Austria, Belgium, Australia. All countries.

Affected products in Canada

CountryProductCompanySinceExpected backReason
CARIVA-ZOLMITRIPTAN (6 & 30)LABORATOIRE RIVA INC14 Oct 2016not givenManufacturing problem
Disruption of the manufacture of the drug
CAMAR-ZOLMITRIPTAN (6 Tablet)MARCAN PHARMACEUTICALS INC1 Apr 2017not givenDistribution or logistics
Delay in shipping of the drug
CASEPTA-ZOLMITRIPTAN-ODT (6s)SEPTA PHARMACEUTICALS INC27 Jun 2017not givenManufacturing problem
Disruption of the manufacture of the drug
CAJAMP-ZOLMITRIPTAN ODT (6)JAMP PHARMA CORPORATION8 Jan 2018not givenManufacturing problem
Disruption of the manufacture of the drug
CAJAMP-ZOLMITRIPTAN ODT (6)JAMP PHARMA CORPORATION12 Oct 2018not givenManufacturing problem
Disruption of the manufacture of the drug
CAJAMP ZOLMITRIPTAN (6 (blister pack))JAMP PHARMA CORPORATION9 Feb 2022not givenManufacturing problem
Disruption of the manufacture of the drug
CATEVA-ZOLMITRIPTAN OD (P PACK 6)TEVA CANADA LIMITED18 Mar 2022not givenManufacturing problem
Disruption of the manufacture of the drug
CASANDOZ ZOLMITRIPTAN ODT (2ODT)SANDOZ CANADA INCORPORATED23 Apr 20248 Sep 2028Manufacturing problem
Disruption of the manufacture of the drug
CASANDOZ ZOLMITRIPTAN ODT (6ODT)SANDOZ CANADA INCORPORATED12 Jun 20248 Sep 2028Manufacturing problem
Disruption of the manufacture of the drug
CAZOLMITRIPTAN ODT (6)SANIS HEALTH INC11 Sep 2024not givenManufacturing problem
Disruption of the manufacture of the drug
CAZOLMITRIPTAN (6)SANIS HEALTH INC14 Apr 2025not givenManufacturing problem
Disruption of the manufacture of the drug
CASANDOZ ZOLMITRIPTAN (3FCT)SANDOZ CANADA INCORPORATED5 May 20258 Sep 2028Manufacturing problem
Disruption of the manufacture of the drug
CASANDOZ ZOLMITRIPTAN (6FCT)SANDOZ CANADA INCORPORATED9 Jun 20258 Sep 2028Manufacturing problem
Disruption of the manufacture of the drug

Source

Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.